Pfizer Canada Inc. is the Canadian operation of Pfizer Inc, the world's leading pharmaceutical company. Pfizer discovers, develops, manufactures and markets prescription medicines for humans and animals. Pfizer Inc invests more than US$7 billion annually in R&D to discover and develop innovative life-saving and life-enhancing medicines in a wide range of therapeutic areas, including arthritis, cardiovascular disease, endocrinology, HIV/AIDS, infectious disease, neurological disease, oncology, ophthalmology and smoking cessation.

Pfizer Canada is a leader in Canadian healthcare research, investing more than $137 million in research and development activities, contributions and partnerships in 2007. As one of the top corporate charitable donors in Canada, Pfizer Canada is a proud member of Imagine Canada and its Caring Company program. In 2007, Pfizer Canada's Community Investment Program supported more than 1,400 non-profit organizations and projects across the country with a total investment of over $25 million.
Headquartered in Kirkland, Quebec, Pfizer Canada and its cross-Canada team of 1,200 employees are working together for a healthier world. Pfizer Canada’s commitment to helping Canadians live happier, healthier and longer lives extends beyond medication.

For more information about Pfizer Canada’s commitment to medical research, our company and how we give back to communities across Canada, please visit www.pfizer.ca.

To learn more about how we’re helping to encourage Canadians to live healthy, balanced lives, visit www.morethanmedication.ca

For more information, contact Cindy Mark Editor, Conferences.

This page was last updated: March 20, 2009